APA (7th ed.) Citation

I, B., D, F., A, R., I, S., G, C., S, D., . . . N, C. (2026). Impact of neoadjuvant chemotherapy on homologous recombination deficiency test results in patients with advanced high-grade serous ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 36(8), 104789. https://doi.org/10.1016/j.ijgc.2026.104789

Chicago Style (17th ed.) Citation

I, Betella, et al. "Impact of Neoadjuvant Chemotherapy on Homologous Recombination Deficiency Test Results in Patients with Advanced High-grade Serous Ovarian Cancer." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 36, no. 8 (2026): 104789. https://doi.org/10.1016/j.ijgc.2026.104789.

MLA (9th ed.) Citation

I, Betella, et al. "Impact of Neoadjuvant Chemotherapy on Homologous Recombination Deficiency Test Results in Patients with Advanced High-grade Serous Ovarian Cancer." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 36, no. 8, 2026, p. 104789, https://doi.org/10.1016/j.ijgc.2026.104789.